The latest price target for Apyx Medical (NASDAQ:APYX) was reported by Craig-Hallum on March 11, 2026. The analyst firm set a price target for $6.00 expecting APYX to rise to within 12 months (a possible 56.25% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Apyx Medical (NASDAQ:APYX) was provided by Craig-Hallum, and Apyx Medical maintained their buy rating.

The last upgrade for Apyx Medical Corp happened on March 11, 2026 when BTIG raised their price target to $6. BTIG previously had a neutral for Apyx Medical Corp.

There is no last downgrade for Apyx Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apyx Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apyx Medical was filed on March 11, 2026 so you should expect the next rating to be made available sometime around March 11, 2027.

While ratings are subjective and will change, the latest Apyx Medical (APYX) rating was a maintained with a price target of $5.00 to $6.00. The current price Apyx Medical (APYX) is trading at is $3.84, which is out of the analyst’s predicted range.